A NOVEL PHARMACEUTICAL FOR ORAL ADMINISTRATION COMPRISING PROGRESTERONE AND A POLYETHYELENE GLYCOL TOGETHER WITH AN EXCIPIENT
申请人:NOVO NORDISK A/S
公开号:EP0789560A1
公开(公告)日:1997-08-20
[EN] A NOVEL PHARMACEUTICAL FOR ORAL ADMINISTRATION COMPRISING PROGRESTERONE AND A POLYETHYELENE GLYCOL TOGETHER WITH AN EXCIPIENT<br/>[FR] NOUVEAU PRODUIT PHARMACEUTIQUE DESTINE A ETRE ADMINISTRE PAR VOIE ORALE ET COMPRENANT DE LA PROGESTERONE, UN POLYETHYLENE GLYCOL AINSI QU'UN EXCIPIENT
申请人:NOVO NORDISK A/S
公开号:WO1995005807A1
公开(公告)日:1995-03-02
(EN) A pharmaceutical composition for oral administration of progesterone may, conveniently, contain a PEG, and a further excipient selected from the group comprising a starch, a cellulose, pecting, and tragacanth.(FR) L'invention se rapporte à un produit pharmaceutique servant à l'administration par voie orale de la progestérone, ce produit pouvant contenir de manière appropriée un polyéthylène glycol ainsi qu'un autre excipient choisi dans le groupe comprenant un amidon, une cellulose, une pectine et un tragacanthe.
DEHYDROGENATION CATALYST, AND CARBONYL COMPOUND AND HYDROGEN PRODUCTION METHOD USING SAID CATALYST
申请人:Kanto Kagaku Kabushiki Kaisha
公开号:US20150086473A1
公开(公告)日:2015-03-26
Objects of the present invention are to provide a novel dehydrogenation reaction catalyst, to provide a method that can produce a ketone, an aldehyde, and a carboxylic acid with high efficiency from an alcohol, and to provide a method for efficiently producing hydrogen from an alcohol, formic acid, or a formate, and they are accomplished by a catalyst containing an organometallic compound of Formula (1).